Mid-America Angels investment network sets record pace in 2015

LENEXA, Kan. – (April 1, 2015) – The Mid-America Angels investment network (MAA) deployed over $870,000 in commercialization funding in Q1 of 2015. This puts MAA on pace to exceed the $2.3 million members of the network invested in six deals last year. MAA’s Q1 activity included a $696,000 investment in Olathe, Kan.-based TVAX Animal Health and a $178,000 investment, led by …

Mid-America Angels investment network recaps 2014 success

LENEXA, Kan. – (January 26, 2015) – The Mid-America Angels (MAA) marked a successful year in 2014, closing a total of six investments. Since the beginning of last year, the MAA network has provided over $2.3 million in commercialization funding to area startups and high-growth businesses. “We’re consistently thrilled to welcome companies to the MAA portfolio. We look forward to working with …

Mid-America Angels announces 57th investment

Lenexa, Kan. – (August 26, 2014) – The Mid-America Angels (MAA) recently closed a $360,000 investment in ClaimKit LLC, an Overland Park-based claim document management and review software company. The deal was syndicated, with an additional $200,000 investment coming from SeedStep Angels in Oklahoma and included participation from the Women’s Capital Connection. This puts ClaimKit within striking distance of meeting …

Angel Investor Capital Investment Portfolio Company Award

Mid-America Angels portfolio company EyeVerify selected as a winner of the 2014 Angel Capital Association Luis Villalobos Award

Lenexa, KS and Washington, D.C. – (March 28, 2014) – Mid-America Angels (MAA) is pleased to announce EyeVerify, a portfolio company since 2012, has received the 2014 Luis Villalobos Award, presented by the Angel Capital Association (ACA). The winner was announced at an awards dinner during the national ACA Summit in Washington, DC on Thursday, March 27th.

ECJC client ImmunoGenetix announces Richard Ogden, PhD, as new head of Scientific Advisory Board

Lenexa Kan. Dr. Ogden joined Agouron Pharmaceuticals, Inc. as a founding scientist at its inception in 1984, where he held positions of Group Leader of Medicinal Chemistry, Principal Scientist, and Senior Director of Scientific Development. He was a team member in the HIV project which led to the discovery and development of Nelfinavir (Viracept®).

ECJC announces George Hansen as new President & CEO

LENEXA, Kan. – (June 17, 2013) – The Enterprise Center of Johnson County (ECJC), a venture development organization and early stage company incubator in the Kansas City Metro, today announced the appointment of George Hansen as President & CEO. Mr. Hansen joins ECJC as a next step in his distinguished career of building and financing companies across multiple industries in …

ECJC’s Joel Wiggins Wins International Award

ATHENS, Ohio – The National Business Incubation Association awarded Joel Wiggins with the 2013 President’s Award during NBIA’s International Conference on Business Incubation in Boston. This award recognizes a longtime NBIA member for lifetime achievement in support of business incubation. A 16-year veteran incubation professional, frequent presenter at NBIA conferences, and former NBIA board member and chairman, Wiggins is leaving …

Demand for Electric Vehicle Charging Stations Fuels LilyPad EV’s Growth

LENEXA, Kan.  –LilyPad EV, a provider of electric vehicle charging station products and services, has recently increased its geographic reach to serve customers across the U.S. LilyPad EV’s recent growth stems from a robust electric vehicle market and the need for reliable and convenient charging options. Currently there are over 5,000 electric car charging stations across the U.S. But with …